Most Popular

Top Stocks With Solid Shareholder Yield Amid Rising AI Valuation Concern

Artificial intelligence remains the dominant investment theme of 2026, but the spectacular rally in AI-linked stocks is increasingly raising concerns about stretched valuations. Investors have poured capital into semiconductor makers, hyperscalers and Artificial Intelligence (AI) software firms on expectations of transformative long-term growth. However, recent …

Read more

Why Microsoft Distancing Itself From OpenAI Is a Good Thing for Investors

Key Points The marriage between Microsoft (NASDAQ: MSFT) and OpenAI started strong, but has since cracked, and the two may end up parting ways completely. If the relationship dissolves entirely, this may actually be good news for Microsoft’s investors. OpenAI’s multi-billion-dollar infrastructure agreement with Amazon …

Read more

Wall Street Just Cut Figma’s Price Target. History Says That’s the Time to Buy.

Key Points Figma has steadily dropped for most of its short trading history. The past behavior of Apple and Netflix after notable price target cuts bodes well for Figma’s stock. 10 stocks we like better than Figma › Investment firm Goldman Sachs recently cut the …

Read more

Tuesday’s ETF with Unusual Volume: SDOG

The ALPS Sector Dividend Dogs ETF is seeing unusually high volume in afternoon trading Tuesday, with over 788,000 shares traded versus three month average volume of about 30,000. Shares of SDOG were up about 0.9% on the day. Components of that ETF with the highest …

Read more

Notable ETF Inflow Detected – AVEM, BABA, ASX, IBN

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Avantis Emerging Markets Equity ETF (Symbol: AVEM) where we have detected an approximate $316.4 million dollar inflow — that’s a 1.3% increase week over week …

Read more

AGEN BOT+BAL: What the BATTMAN Trial Means for mCRC

Agenus AGEN centered its investment case on botensilimab plus balstilimab (BOT+BAL), a checkpoint combination being advanced in refractory microsatellite stable (MSS)/mismatch repair proficient (pMMR) metastatic colorectal cancer (mCRC). The target market is one of the most stubborn gaps in solid-tumor immunotherapy, where standard checkpoint inhibitors …

Read more

2 Surefire Ways to Invest in SpaceX Now (and After) Its Historic IPO

Key Points All eyes are on SpaceX as the Elon Musk-led company prepares for what may be the biggest initial public offering ever. The technology and industrial giant aims for a valuation that may approach $2 trillion. Though SpaceX hasn’t announced an exact date for …

Read more

Meta Platforms Is Down 21% From Its All-Time High: Here’s What History Says Will Happen Next

Key Points Meta Platforms (NASDAQ: META) has faced several challenges over the past 12 months. Investors aren’t convinced that the company’s significant capex spending will pay off, and although its financial results have been strong, they often weren’t quite impressive enough to assuage those fears. …

Read more

Crypto Market Update: Strategy Tumbles After Saylor Breaks “Never Sell” Rule

Here’s a quick recap of the crypto landscape for Wednesday (June 3) as of 8:00 p.m. UTC. Get the latest insights on Bitcoin, Ether and altcoins, along with a round-up of key cryptocurrencymarket news Bitcoin (BTC) was priced at US$65,978.75, trading 1.9 percent lower over …

Read more

Nebius Stock Is Up 170% in 2026, and Leopold Aschenbrenner Just Bought a 5.6% Stake. Here’s Why

Key Points Leopold Aschenbrenner, a prominent German AI researcher and investor who previously worked at OpenAI, recently acquired a 5.6% stake in the cloud-based AI infrastructure company Nebius (NASDAQ: NBIS) through his Situational Awareness fund. That purchase might seem surprising, since Nebius’ stock has already …

Read more